Logo image of HY

HYSTER-YALE INC (HY) Stock Fundamental Analysis

NYSE:HY - New York Stock Exchange, Inc. - US4491721050 - Common Stock - Currency: USD

42.54  +0.27 (+0.64%)

Fundamental Rating

4

We assign a fundamental rating of 4 out of 10 to HY. HY was compared to 128 industry peers in the Machinery industry. While HY is still in line with the averages on profitability rating, there are concerns on its financial health. HY is cheap, but on the other hand it scores bad on growth. Finally HY also has an excellent dividend rating.


Dividend Valuation Growth Profitability Health

5

1. Profitability

1.1 Basic Checks

HY had positive earnings in the past year.
In the past year HY had a positive cash flow from operations.
In multiple years HY reported negative net income over the last 5 years.
HY had a positive operating cash flow in 4 of the past 5 years.
HY Yearly Net Income VS EBIT VS OCF VS FCFHY Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M 200M -200M

1.2 Ratios

With a Return On Assets value of 4.84%, HY perfoms like the industry average, outperforming 52.34% of the companies in the same industry.
With an excellent Return On Equity value of 19.49%, HY belongs to the best of the industry, outperforming 82.03% of the companies in the same industry.
HY's Return On Invested Capital of 12.74% is fine compared to the rest of the industry. HY outperforms 78.13% of its industry peers.
Industry RankSector Rank
ROA 4.84%
ROE 19.49%
ROIC 12.74%
ROA(3y)3.14%
ROA(5y)0.52%
ROE(3y)8.66%
ROE(5y)-3.29%
ROIC(3y)N/A
ROIC(5y)N/A
HY Yearly ROA, ROE, ROICHY Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 -40

1.3 Margins

With a Profit Margin value of 2.39%, HY perfoms like the industry average, outperforming 40.63% of the companies in the same industry.
HY's Profit Margin has improved in the last couple of years.
With a Operating Margin value of 4.93%, HY is not doing good in the industry: 62.50% of the companies in the same industry are doing better.
HY's Operating Margin has improved in the last couple of years.
HY has a worse Gross Margin (20.12%) than 72.66% of its industry peers.
HY's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 4.93%
PM (TTM) 2.39%
GM 20.12%
OM growth 3YN/A
OM growth 5Y29.18%
PM growth 3YN/A
PM growth 5Y24.88%
GM growth 3Y20.72%
GM growth 5Y4.68%
HY Yearly Profit, Operating, Gross MarginsHY Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 -5 10 15 20

3

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), HY is creating some value.
Compared to 1 year ago, HY has more shares outstanding
HY has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, HY has an improved debt to assets ratio.
HY Yearly Shares OutstandingHY Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M
HY Yearly Total Debt VS Total AssetsHY Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B

2.2 Solvency

HY has an Altman-Z score of 3.14. This indicates that HY is financially healthy and has little risk of bankruptcy at the moment.
HY has a Altman-Z score (3.14) which is comparable to the rest of the industry.
HY has a debt to FCF ratio of 7.93. This is a slightly negative value and a sign of low solvency as HY would need 7.93 years to pay back of all of its debts.
HY has a Debt to FCF ratio (7.93) which is comparable to the rest of the industry.
A Debt/Equity ratio of 0.67 indicates that HY is somewhat dependend on debt financing.
HY has a worse Debt to Equity ratio (0.67) than 67.19% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.67
Debt/FCF 7.93
Altman-Z 3.14
ROIC/WACC1.44
WACC8.85%
HY Yearly LT Debt VS Equity VS FCFHY Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M 400M 600M

2.3 Liquidity

HY has a Current Ratio of 1.38. This is a normal value and indicates that HY is financially healthy and should not expect problems in meeting its short term obligations.
HY has a Current ratio of 1.38. This is in the lower half of the industry: HY underperforms 79.69% of its industry peers.
HY has a Quick Ratio of 1.38. This is a bad value and indicates that HY is not financially healthy enough and could expect problems in meeting its short term obligations.
The Quick ratio of HY (0.65) is worse than 89.84% of its industry peers.
Industry RankSector Rank
Current Ratio 1.38
Quick Ratio 0.65
HY Yearly Current Assets VS Current LiabilitesHY Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B

2

3. Growth

3.1 Past

The earnings per share for HY have decreased strongly by -24.57% in the last year.
Measured over the past years, HY shows a very strong growth in Earnings Per Share. The EPS has been growing by 35.91% on average per year.
Looking at the last year, HY shows a decrease in Revenue. The Revenue has decreased by -0.32% in the last year.
Measured over the past years, HY shows a small growth in Revenue. The Revenue has been growing by 5.53% on average per year.
EPS 1Y (TTM)-24.57%
EPS 3YN/A
EPS 5Y35.91%
EPS Q2Q%-83.28%
Revenue 1Y (TTM)-0.32%
Revenue growth 3Y11.89%
Revenue growth 5Y5.53%
Sales Q2Q%-13.83%

3.2 Future

HY is expected to show a very negative growth in Earnings Per Share. In the coming years, the EPS will decrease by -15.29% yearly.
HY is expected to show a decrease in Revenue. In the coming years, the Revenue will decrease by -1.32% yearly.
EPS Next Y-74.16%
EPS Next 2Y-35.54%
EPS Next 3Y-25.66%
EPS Next 5Y-15.29%
Revenue Next Year-13.37%
Revenue Next 2Y-5.74%
Revenue Next 3Y-3.13%
Revenue Next 5Y-1.32%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
HY Yearly Revenue VS EstimatesHY Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 1B 2B 3B 4B
HY Yearly EPS VS EstimatesHY Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 0 5 -5

7

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 6.53 indicates a rather cheap valuation of HY.
HY's Price/Earnings ratio is rather cheap when compared to the industry. HY is cheaper than 97.66% of the companies in the same industry.
When comparing the Price/Earnings ratio of HY to the average of the S&P500 Index (27.45), we can say HY is valued rather cheaply.
The Price/Forward Earnings ratio is 11.44, which indicates a very decent valuation of HY.
Based on the Price/Forward Earnings ratio, HY is valued cheaper than 88.28% of the companies in the same industry.
HY is valuated rather cheaply when we compare the Price/Forward Earnings ratio to 21.90, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 6.53
Fwd PE 11.44
HY Price Earnings VS Forward Price EarningsHY Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

98.44% of the companies in the same industry are more expensive than HY, based on the Enterprise Value to EBITDA ratio.
Based on the Price/Free Cash Flow ratio, HY is valued cheaply inside the industry as 90.63% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 12.35
EV/EBITDA 4.21
HY Per share dataHY EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 50 100 150 200

4.3 Compensation for Growth

HY's earnings are expected to decrease with -25.66% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)0.18
EPS Next 2Y-35.54%
EPS Next 3Y-25.66%

7

5. Dividend

5.1 Amount

HY has a Yearly Dividend Yield of 3.59%. Purely for dividend investing, there may be better candidates out there.
HY's Dividend Yield is rather good when compared to the industry average which is at 1.83. HY pays more dividend than 92.97% of the companies in the same industry.
HY's Dividend Yield is rather good when compared to the S&P500 average which is at 2.38.
Industry RankSector Rank
Dividend Yield 3.59%

5.2 History

The dividend of HY has a limited annual growth rate of 1.92%.
HY has paid a dividend for at least 10 years, which is a reliable track record.
HY has not decreased their dividend for at least 10 years, which is a reliable track record.
Dividend Growth(5Y)1.92%
Div Incr Years11
Div Non Decr Years11
HY Yearly Dividends per shareHY Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.2 0.4 0.6 0.8 1

5.3 Sustainability

24.65% of the earnings are spent on dividend by HY. This is a low number and sustainable payout ratio.
DP24.65%
EPS Next 2Y-35.54%
EPS Next 3Y-25.66%
HY Yearly Income VS Free CF VS DividendHY Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M -200M
HY Dividend Payout.HY Dividend Payout, showing the Payout Ratio.HY Dividend Payout.PayoutRetained Earnings

HYSTER-YALE INC

NYSE:HY (7/3/2025, 7:34:44 PM)

42.54

+0.27 (+0.64%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryMachinery
Earnings (Last)05-06 2025-05-06/amc
Earnings (Next)08-04 2025-08-04/amc
Inst Owners61.49%
Inst Owner Change0.43%
Ins Owners18.03%
Ins Owner Change6.74%
Market Cap753.38M
Analysts82
Price Target57.12 (34.27%)
Short Float %4.09%
Short Ratio6.79
Dividend
Industry RankSector Rank
Dividend Yield 3.59%
Yearly Dividend1.39
Dividend Growth(5Y)1.92%
DP24.65%
Div Incr Years11
Div Non Decr Years11
Ex-Date05-30 2025-05-30 (0.36)
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)2.32%
Min EPS beat(2)1.22%
Max EPS beat(2)3.42%
EPS beat(4)3
Avg EPS beat(4)4.29%
Min EPS beat(4)-52.2%
Max EPS beat(4)64.73%
EPS beat(8)6
Avg EPS beat(8)52.96%
EPS beat(12)9
Avg EPS beat(12)87.66%
EPS beat(16)10
Avg EPS beat(16)10.14%
Revenue beat(2)1
Avg Revenue beat(2)-2.68%
Min Revenue beat(2)-6.74%
Max Revenue beat(2)1.38%
Revenue beat(4)2
Avg Revenue beat(4)-1.76%
Min Revenue beat(4)-6.74%
Max Revenue beat(4)4.95%
Revenue beat(8)4
Avg Revenue beat(8)0.58%
Revenue beat(12)7
Avg Revenue beat(12)1.59%
Revenue beat(16)9
Avg Revenue beat(16)0.92%
PT rev (1m)-22.76%
PT rev (3m)-22.76%
EPS NQ rev (1m)0%
EPS NQ rev (3m)14.42%
EPS NY rev (1m)0%
EPS NY rev (3m)-58.35%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-6.67%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-5.61%
Valuation
Industry RankSector Rank
PE 6.53
Fwd PE 11.44
P/S 0.18
P/FCF 12.35
P/OCF 6.73
P/B 1.48
P/tB 1.77
EV/EBITDA 4.21
EPS(TTM)6.51
EY15.3%
EPS(NY)3.72
Fwd EY8.74%
FCF(TTM)3.44
FCFY8.1%
OCF(TTM)6.32
OCFY14.85%
SpS235.01
BVpS28.8
TBVpS24.04
PEG (NY)N/A
PEG (5Y)0.18
Profitability
Industry RankSector Rank
ROA 4.84%
ROE 19.49%
ROCE 20.48%
ROIC 12.74%
ROICexc 13.7%
ROICexgc 14.93%
OM 4.93%
PM (TTM) 2.39%
GM 20.12%
FCFM 1.47%
ROA(3y)3.14%
ROA(5y)0.52%
ROE(3y)8.66%
ROE(5y)-3.29%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5Y35.18%
ROICexc growth 3YN/A
ROICexc growth 5Y37.6%
OM growth 3YN/A
OM growth 5Y29.18%
PM growth 3YN/A
PM growth 5Y24.88%
GM growth 3Y20.72%
GM growth 5Y4.68%
F-Score6
Asset Turnover2.03
Health
Industry RankSector Rank
Debt/Equity 0.67
Debt/FCF 7.93
Debt/EBITDA 1.35
Cap/Depr 108.53%
Cap/Sales 1.22%
Interest Coverage 250
Cash Conversion 44.4%
Profit Quality 61.37%
Current Ratio 1.38
Quick Ratio 0.65
Altman-Z 3.14
F-Score6
WACC8.85%
ROIC/WACC1.44
Cap/Depr(3y)81.76%
Cap/Depr(5y)92.33%
Cap/Sales(3y)0.93%
Cap/Sales(5y)1.21%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-24.57%
EPS 3YN/A
EPS 5Y35.91%
EPS Q2Q%-83.28%
EPS Next Y-74.16%
EPS Next 2Y-35.54%
EPS Next 3Y-25.66%
EPS Next 5Y-15.29%
Revenue 1Y (TTM)-0.32%
Revenue growth 3Y11.89%
Revenue growth 5Y5.53%
Sales Q2Q%-13.83%
Revenue Next Year-13.37%
Revenue Next 2Y-5.74%
Revenue Next 3Y-3.13%
Revenue Next 5Y-1.32%
EBIT growth 1Y-17.93%
EBIT growth 3YN/A
EBIT growth 5Y36.32%
EBIT Next Year-41.33%
EBIT Next 3Y-11.06%
EBIT Next 5Y-6.6%
FCF growth 1Y291.22%
FCF growth 3YN/A
FCF growth 5Y35.41%
OCF growth 1Y1277.89%
OCF growth 3YN/A
OCF growth 5Y17.35%